Abstract
Aminoacyl-tRNA synthetases are an ancient family of enzymes that are essential in determining and accurately maintaining the genetic code. In the initial step of protein synthesis, the aminoacylation process requires each synthetase to specifically recognize and bind its cognate tRNA and to catalyze the transfer of the appropriate amino acid to the acceptor stem of the tRNA. The aminoacylation in the cytoplasm and mitochondria is largely performed by distinct sets of synthetases, which are encoded by separate nuclear genes. This separation is thought to be the consequence of evolutionary pressure of mitochondrial DNA size reduction, which has resulted in truncated tRNAs and subsequent inability of cytoplasmic aminoacyl-tRNA synthetases to recognize the mitochondrial tRNAs. Two enzymes, glycyl-and lysyl-tRNA synthetase, are exceptions because the same nuclear genes (GARS and KARS, respectively) encode both the cytoplasmic and the mitochondrial protein.
Patients with autosomal-recessive mutations in six genes (DARS2, RARS2, YARS2, SARS2, HARS2, and AARS2) encoding mitochondrial aminoacyl-tRNA synthetases have recently been reported, making this group of enzymes a new important cause of protein synthesis defects in the mitochondria. In addition, dominant mutations in GARS and KARS underlie Charcot-Marie-Tooth neuropathy. Deficient mitochondrial translation could be expected to reduce OXPHOS capacity and lead to ATP-deficiency in all tissues, primarily affecting the high-energy demanding tissues such as brain, heart, and skeletal muscle. Surprisingly, however, the defects in mitochondrial aminoacyl-tRNA synthetases have been identified in different types of tissue-specific disorders. The mechanism for the tissue-specificity is not currently understood.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schimmel P, Söll D (2005) The world of aminoacyl-tRNA synthetases. In: Ibba M, Francklyn C, Cusack S (eds) The aminoacyl-tRNA synthetases. Landes Bioscience, Georgetown, pp 1–3
Watanabe K (2010) Unique features of animal mitochondrial translation systems. The non-universal genetic code, unusual features of the translational apparatus and their relevance to human mitochondrial diseases. Proc Jpn Acad Ser B Phys Biol Sci 86:11–39
Nagao A, Suzuki T, Katoh T, Sakaguchi Y (2009) Biogenesis of glutaminyl-mt tRNAGln in human mitochondria. Proc Natl Acad Sci U S A 106:16209–16214
van der Knaap MS, van der Voorn P, Barkhof F et al (2003) A new leukoencephalopathy with brainstem and spinal cord involvement and high lactate. Ann Neurol 53:252–258
Linnankivi T, Lundbom N, Autti T et al (2004) Five new cases of a recently described leukoencephalopathy with high brain lactate. Neurology 63:688–692
Scheper GC, van der Klok T, van Andel RJ et al (2007) Mitochondrial aspartyl-tRNA synthetase deficiency causes leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation. Nat Genet 39:534–539
van Berge L, Dooves S, van Berkel CG, Polder E, van der Knaap MS, Scheper GC (2012) Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation is associated with cell type-dependent splicing of mtAspRS mRNA. Biochem J 441(3):955–962
Lin J, Chiconelli Faria E, Da Rocha AJ et al (2010) Leukoencephalopathy with brainstem and spinal cord involvement and normal lactate: a new mutation in the DARS2 gene. J Child Neurol 25:1425–1428
Tzoulis C, Tran GT, Gjerde IO et al (2012) Leukoencephalopathy with brainstem and spinal cord involvement caused by a novel mutation in the DARS2 gene. J Neurol 259(2):292–296
Synofzik M, Schicks J, Lindig T et al (2011) Acetazolamide-responsive exercise-induced episodic ataxia associated with a novel homozygous DARS2 mutation. J Med Genet 48:713–715
Miyake N, Yamashita S, Kurosawa K et al (2011) A novel homozygous mutation of DARS2 may cause a severe LBSL variant. Clin Genet 80:293–296
Edvardson S, Shaag A, Kolesnikova O et al (2007) Deleterious mutation in the mitochondrial arginyl-transfer RNA synthetase gene is associated with pontocerebellar hypoplasia. Am J Hum Genet 81:857–862
Rankin J, Brown R, Dobyns WB et al (2010) Pontocerebellar hypoplasia type 6: a British case with PEHO-like features. Am J Med Genet A 152A:2079–2084
Namavar Y, Barth PG, Kasher PR et al (2011) Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia. Brain 134:143–156
Kasher PR, Namavar Y, van Tijn P et al (2011) Impairment of the tRNA-splicing endonuclease subunit 54 (tsen54) gene causes neurological abnormalities and larval death in zebrafish models of pontocerebellar hypoplasia. Hum Mol Genet 20:1574–1584
Yoshihisa T, Yunoki-Esaki K, Ohshima C, Tanaka N, Endo T (2003) Possibility of cytoplasmic pre-tRNA splicing: the yeast tRNA splicing endonuclease mainly localizes on the mitochondria. Mol Biol Cell 14:3266–3279
Bykhovskaya Y, Casas K, Mengesha E, Inbal A, Fischel-Ghodsian N (2004) Missense mutation in pseudouridine synthase 1 (PUS1) causes mitochondrial myopathy and sideroblastic anemia (MLASA). Am J Hum Genet 74:1303–1308
Patton JR, Bykhovskaya Y, Mengesha E, Bertolotto C, Fischel-Ghodsian N (2005) Mitochondrial myopathy and sideroblastic anemia (MLASA): missense mutation in the pseudouridine synthase 1 (PUS1) gene is associated with the loss of tRNA pseudouridylation. J Biol Chem 280:19823–19828
Riley LG, Cooper S, Hickey P et al (2010) Mutation of the mitochondrial tyrosyl-tRNA synthetase gene, YARS2, causes myopathy, lactic acidosis, and sideroblastic anemia—MLASA syndrome. Am J Hum Genet 87:52–59
Fechter P, Rudinger-Thirion J, Theobald-Dietrich A, Giege R (2000) Identity of tRNA for yeast tyrosyl-tRNA synthetase: tyrosylation is more sensitive to identity nucleotides than to structural features. Biochemistry 39:1725–1733
Belostotsky R, Ben-Shalom E, Rinat C et al (2011) Mutations in the mitochondrial seryl-tRNA synthetase cause hyperuricemia, pulmonary hypertension, renal failure in infancy and alkalosis, HUPRA syndrome. Am J Hum Genet 88:193–200
Chimnaronk S, Gravers Jeppesen M, Suzuki T, Nyborg J, Watanabe K (2005) Dual-mode recognition of noncanonical tRNAs(Ser) by seryl-tRNA synthetase in mammalian mitochondria. EMBO J 24:3369–3379
Pierce SB, Chisholm KM, Lynch ED et al (2011) Mutations in mitochondrial histidyl tRNA synthetase HARS2 cause ovarian dysgenesis and sensorineural hearing loss of Perrault syndrome. Proc Natl Acad Sci U S A 108:6543–6548
Gotz A, Tyynismaa H, Euro L et al (2011) Exome sequencing identifies mitochondrial alanyl-tRNA synthetase mutations in infantile mitochondrial cardiomyopathy. Am J Hum Genet 88:635–642
Guo M, Chong YE, Shapiro R, Beebe K, Yang XL, Schimmel P (2009) Paradox of mistranslation of serine for alanine caused by AlaRS recognition dilemma. Nature 462:808–812
t Hart LM, Hansen T, Rietveld I et al (2005) Evidence that the mitochondrial leucyl tRNA synthetase (LARS2) gene represents a novel type 2 diabetes susceptibility gene. Diabetes 54:1892–1895
Reiling E, Jafar-Mohammadi B, van ’t Riet E et al (2010) Genetic association analysis of LARS2 with type 2 diabetes. Diabetologia 53:103–110
Tolkunova E, Park H, Xia J, King MP, Davidson E (2000) The human lysyl-tRNA synthetase gene encodes both the cytoplasmic and mitochondrial enzymes by means of an unusual alternative splicing of the primary transcript. J Biol Chem 275:35063–35069
Chang KJ, Wang CC (2004) Translation initiation from a naturally occurring non-AUG codon in Saccharomyces cerevisiae. J Biol Chem 279:13778–13785
Antonellis A, Ellsworth RE, Sambuughin N et al (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 72:1293–1299
He W, Zhang HM, Chong YE, Guo M, Marshall AG, Yang XL (2011) Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening. Proc Natl Acad Sci U S A 108:12307–12312
Nangle LA, Zhang W, Xie W, Yang XL, Schimmel P (2007) Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc Natl Acad Sci U S A 104:11239–11244
Motley WW, Talbot K, Fischbeck KH (2010) GARS axonopathy: not every neuron’s cup of tRNA. Trends Neurosci 33:59–66
McLaughlin HM, Sakaguchi R, Liu C et al (2010) Compound heterozygosity for loss-of-function lysyl-tRNA synthetase mutations in a patient with peripheral neuropathy. Am J Hum Genet 87:560–566
Jordanova A, Irobi J, Thomas FP et al (2006) Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 38:197–202
Latour P, Thauvin-Robinet C, Baudelet-Mery C et al (2010) A major determinant for binding and aminoacylation of tRNA(Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-Tooth disease. Am J Hum Genet 86:77–82
Zuchner S, Mersiyanova IV, Muglia M et al (2004) Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A. Nat Genet 36:449–451
Li R, Guan MX (2010) Human mitochondrial leucyl-tRNA synthetase corrects mitochondrial dysfunctions due to the tRNALeu(UUR) A3243G mutation, associated with mitochondrial encephalomyopathy, lactic acidosis, and stroke-like symptoms and diabetes. Mol Cell Biol 30:2147–2154
Perli E, Giordano C, Tuppen HA et al (2012) Isoleucyl-tRNA synthetase levels modulate the penetrance of a homoplasmic m.4277T>C mitochondrial tRNAIle mutation causing hypertrophic cardiomyopathy. Hum Mol Genet 21(1):85–100
Rorbach J, Yusoff AA, Tuppen H et al (2008) Overexpression of human mitochondrial valyl tRNA synthetase can partially restore levels of cognate mt-tRNAVal carrying the pathogenic C25U mutation. Nucleic Acids Res 36:3065–3074
Guo M, Yang XL, Schimmel P (2010) New functions of aminoacyl-tRNA synthetases beyond translation. Nat Rev Mol Cell Biol 11:668–674
Crimi M, Galbiati S, Perini MP et al (2003) A mitochondrial tRNA(His) gene mutation causing pigmentary retinopathy and neurosensorial deafness. Neurology 60:1200–1203
Spagnolo M, Tomelleri G, Vattemi G, Filosto M, Rizzuto N, Tonin P (2001) A new mutation in the mitochondrial tRNA(Ala) gene in a patient with ophthalmoplegia and dysphagia. Neuromuscul Disord 11:481–484
Swalwell H, Deschauer M, Hartl H et al (2006) Pure myopathy associated with a novel mitochondrial tRNA gene mutation. Neurology 66:447–449
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Tyynismaa, H. (2013). Mitochondrial Aminoacyl-tRNA Synthetases. In: Wong, LJ. (eds) Mitochondrial Disorders Caused by Nuclear Genes. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-3722-2_16
Download citation
DOI: https://doi.org/10.1007/978-1-4614-3722-2_16
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-3721-5
Online ISBN: 978-1-4614-3722-2
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)